Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data

Christoph Abé, Jaana Keto, Mathias Lilja, Mie Konradsen, Johan Mesterton, Martin Höglund, Vladimir Lazarevic, Sören Lehmann, Gunnar Juliusson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data'. Together they form a unique fingerprint.

Medicine and Dentistry